Work

Gene therapy: science in slow motion.

Year: 2007
Type: article
Abstract: Early-stage human trials of gene therapies that could target some of the world's deadliest diseases are underway. An air of caution lingers, however, as past setbacks remain on investors' minds. Researchers are optimistic about the potential for positive outcomes that could lure biotech companies back.
Author: John Carroll
Language: English
Subfield: Genetics
Open Access status: green
OpenAlex ID: W1901099681
FWCI:
Cites:
Cited by:
Related to: 10